TL;DR
Modern managed care has completed its transition from a traditional insurance underwriting model to a vertically integrated services business. While government-sponsored insurance plans face severe margin compression from rising medical costs, conglomerates are successfully insulating their earnings by routing volume through internal pharmacy benefit managers, specialty pharmacies, and clinical networks. To protect these profit engines, health giants are aggressively shedding high-risk members and contracting their public program footprints while mounting aggressive legal defenses against state-level structural regulation.
The Services Engine Eclipse
Unregulated clinical, pharmacy, and technology services are systematically eclipsing traditional insurance underwriting as the primary profit engines for managed care conglomerates.
"Elevance's Carelon division (comprising CarelonRx and Carelon Services) generated $948 million in operating gain ($582 million from CarelonRx and $366 million from Carelon Services), completely eclipsing the $896 million operating gain of the core Health Benefits insurance segment." — [us-health-insurers-profit-engine-vertical-integration-vs-regulated-margins]
"Total Optum operating earnings guidance is now >$13.45 billion, demonstrating that the services segments collectively remain the primary profit generator for the group." — [unitedhealth-optum-vertical-integration-medicare-advantage]
This structural shift proves that the ultimate value of a covered life is no longer the premium margin, but the volume that can be routed through internal pharmacy and care delivery networks. By turning regulated insurance entities into pass-through vehicles, conglomerates successfully recycle premium dollars into high-margin service profits. This economic reality explains why the largest managed care organizations continue to report robust earnings even as their core insurance margins face severe pressure.
What to watch: Watch for whether Cigna's Evernorth segment continues to command the lion's share of enterprise profitability as it leverages specialty drug adoption and biosimilar expansion [cigna-evernorth-pivot-commercial-focus].
The Margin-Driven Contraction of Public Risk
Major managed care organizations are aggressively shrinking their government-sponsored footprints and shedding unprofitable members to defend their bottom lines against rising medical costs.
"For 2027, we anticipate these plan exits will impact approximately 600,000 members, though we will work to recapture a significant portion of that volume as we did in 2025." — Celeste Mellet, CFO, [humana-medicare-advantage-margin-compression]
"At the end of the day, Medicaid participation has to make strategic and financial sense for us within our diversified portfolio... Where those conditions aren't present, we're going to take the disciplined action that we need to." — Gail Boudreaux, President and CEO, Elevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2
Rather than chasing market share, conglomerates are prioritizing margin over scale by walking away from high-risk government contracts. This disciplined pruning demonstrates that insurers will readily contract their public-sector footprints when the regulatory rate environment fails to cover the actuarial reality of an aging, sicker population. The era of chasing sheer enrollment volume in Medicare Advantage and Medicaid has officially given way to defensive pricing and strategic market exits.
What to watch: Watch for how many additional states Elevance exits over the next 12 to 18 months as it navigates a negative 1.75% Medicaid operating margin forecast [elevance-health-carelon-vertical-integration-internal-margins].
The Battleground Over Structural Integration
State-level efforts to dismantle the vertically integrated healthcare model are triggering an aggressive legal backlash from conglomerates defending their core profit engines.
"The FAIR Rx Act targets pharmacy benefit managers' influence by prohibiting their ownership or control of pharmacies in Tennessee... CVS Caremark reimbursed its affiliated pharmacies up to 16,000% more than non-affiliated pharmacies for the same medications." — Tennessee Pharmacists Association, Governor Lee Signs FAIR Rx Act into Law
"Within weeks of enactment, three separate lawsuits were filed... CVS Caremark, Cigna Express Scripts, and the Pharmaceutical Care Management Association (PCMA)... The plaintiffs argue that the FAIR Rx Act violates the Dormant Commerce Clause... and is federally preempted by ERISA, Medicare, and TRICARE frameworks." — [pbm-vertical-integration-state-ownership-restrictions]
This escalating conflict represents the most existential policy risk to the managed care sector's long-term profitability. If states successfully ban PBMs from owning or controlling pharmacies, they will sever the internal pipeline that allows these conglomerates to capture massive, unregulated margins on specialty drugs. The industry's rapid recourse to federal courts highlights how fiercely they will defend the legal structures that make vertical integration possible.
What to watch: Watch for the Eighth Circuit Court of Appeals' upcoming ruling in Express Scripts, Inc. v. Richmond, which will set a major precedent for the survival of state-level PBM pharmacy ownership bans [pbm-vertical-integration-state-ownership-restrictions].
What surprised us
- Prior period reserve developments are heavily flattening MCR numbers. While underlying medical costs remain highly volatile, insurers are successfully smoothing their quarterly results using massive reserve adjustments. UnitedHealth reported a staggering $860 million of net favorable prior period medical development [unitedhealth-optum-vertical-integration-medicare-advantage]
, and CVS Health's Aetna segment utilized $500 million of favorable prior year development to lower its MBR by 140 basis points [cvs-health-caremark-aetna-margin-recovery]
- Cigna's hyper-focus on commercial employer plans is looking brilliant. While its peers struggle with the volatile risk pools of government-sponsored plans, Cigna's deliberate avoidance of Medicaid and individual ACA exchanges insulated it from sector-wide medical cost spikes, allowing Cigna Healthcare to grow pre-tax income by 17% [cigna-evernorth-pivot-commercial-focus]
.
- The legal defense of vertical integration is successfully leveraging ERISA preemption. PBMs scored a major victory when the Eighth Circuit ruled in Flowers v. Caremark PCS Health, LLC that Arkansas's geographic coverage requirements were preempted by ERISA, demonstrating that federal law remains a powerful shield against state-level pharmacy network regulations [pbm-vertical-integration-state-ownership-restrictions]
.